Pediatr. praxi. 2020;21(1):17-21 | DOI: 10.36290/ped.2020.009

Rhabdomyolysis in children

MUDr. Jan David, Ph.D., MUDr. Michaela Šibíková, doc. MUDr. Filip Fencl, Ph.D.
Pediatrická klinika 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha

In pediatric population, the prevalence of rhabdomyolysis is unknown. A clinical manifestation is wide - from asymptomatic to life-threatening. The intracellular components leakage from disintegrated muscle into the circulation is associated with the risk of myoglobinuria and acute kidney injury, hypovolaemia and mineral dysbalances. The article presents etiopathogenesis, clinical manifestations, diagnostic procedure and therapy of rhabdomyolysis in children.

Keywords: rhabdomyolysis, myositis, creatine kinase, myoglobin, pediatrics.

Received: December 6, 2019; Revised: January 16, 2020; Accepted: January 16, 2020; Prepublished online: January 16, 2020; Published: March 19, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
David J, Šibíková M, Fencl F. Rhabdomyolysis in children. Pediatr. praxi. 2020;21(1):17-21. doi: 10.36290/ped.2020.009.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vanholder R, Sűkrű Sever M, Erek E, et al. Rhabdomyolysis. J Am Soc Nephrol. 2000; 11 (8): 1553-1561. Go to original source... Go to PubMed...
    2. Chan EK, Kornberg AJ, Ryan MM. A diagnostic approach to recurrent myalgia and rhabdomyolysis in children. Arch Dis Child. 2015; 100: 793-797. Go to original source...
    3. David J, Chrastina P, Pešková K, et al. Epidemiology of rare diseases detected by newborn screening in the Czech Republic. Cent Eur J Publ Heal. 2019; 27 (2): 153-159. Go to original source...
    4. Souček M, Pálová S, Charvát J. Akutní selhání ledvin u kriticky nemocných pacientů s rhabdomyolýzou. Interni Med Praxi. 2005; 11: 489-491.
    5. Huerta‑Alardín AL, Varon J, Marik PE. Bench‑to‑bedside review: Rhabdomyolysis - an overview for clinicians. Crit Care. 2005; 9 (2): 158-169. Go to original source...
    6. Ševčík P, Matějovič M, ed. Intenzivní medicína. 3., přeprac. a rozš. vyd. Praha: Galén, c2014: 1195.
    7. Al‑ Ismaili Z, Piccioni M, Zappitelli M. Rhabdomyolysis: pathogenesis of renal injury and management. Pediatr Nephrol. 2011; 26 (10): 1781-1788. Go to original source... Go to PubMed...
    8. Racek J, Petříková V, Rajdl D. Rabdomyolýza vyvolaná nadměrnou svalovou zátěží - častá příčina chybné diagnózy. Klin Biochem Metabol. 2017; 25 (46): 72-76.
    9. Rucki Š, Hrubá E. Rhabdomyolýza jako projev vrozené poruchy energetického metabolizmu u dvouletého chlapce. Pediatr. praxi 2014; 15 (1): 38-41.
    10. Lappalainen H, Tiula E, Uotila L, et al. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: Implications for follow‑up. Crit Care Med 2002; 30 (10): 2212-2215. Go to original source...
    11. Park Y, Song JY, Kim SY, et al. Clinical Characteristics of Rhabdomyolysis in Children: Single Center Experience. Child Kidney Dis 2018; 22 (2): 52-57. Go to original source...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.